'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Five Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Helicobacter pylori Infections to Infectious Disease Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Helicobacter pylori Infections to Infectious Disease Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Helicobacter pylori Infections Therapeutics Clinical Trials 27
Prominent Drugs 29
Latest Clinical Trials News on Helicobacter pylori Infections 30
Nov 10, 2016: RedHill Biopharma Reports Positive FDA Type B Meeting on RHB-105 for H. pylori Infection Ahead of Confirmatory Phase III Study 30
Clinical Trial Profile Snapshots 31
Appendix 283
Abbreviations 283
Definitions 283
Research Methodology 284
Secondary Research 284
About GlobalData 285
Contact Us 285
Disclaimer 285
Source 286
List of Tables
Helicobacter pylori Infections Therapeutics, Global, Clinical Trials by Region, 2016* 6
Helicobacter pylori Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Helicobacter pylori Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
Helicobacter pylori Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 9
Helicobacter pylori Infections Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10
Helicobacter pylori Infections Therapeutics Clinical Trials, North America, Top Countries, 2016* 11
Helicobacter pylori Infections Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016* 12
Helicobacter pylori Infections Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2016* 13
Proportion of Helicobacter pylori Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2016* 14
Helicobacter pylori Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
Helicobacter pylori Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
Proportion of Helicobacter pylori Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2016* 17
Helicobacter pylori Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
Helicobacter pylori Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19
Helicobacter pylori Infections Therapeutics, Global, Clinical Trials by Phase, 2016* 20
Helicobacter pylori Infections Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 21
Helicobacter pylori Infections Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22
Helicobacter pylori Infections Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23
Helicobacter pylori Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24
Helicobacter pylori Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 25
Helicobacter pylori Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26
Helicobacter pylori Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 28
Helicobacter pylori Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 29
List of Figures
Helicobacter pylori Infections Therapeutics, Global, Clinical Trials by Region (%), 2016* 6
Helicobacter pylori Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Helicobacter pylori Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
Helicobacter pylori Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 9
Helicobacter pylori Infections Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10
Helicobacter pylori Infections Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11
Helicobacter pylori Infections Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016* 12
Helicobacter pylori Infections Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2016* 13
Proportion of Helicobacter pylori Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2016* 14
Helicobacter pylori Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
Helicobacter pylori Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
Proportion of Helicobacter pylori Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2016* 17
Helicobacter pylori Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
Helicobacter pylori Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19
Helicobacter pylori Infections Therapeutics, Global, Clinical Trials by Phase (%), 2016* 20
Helicobacter pylori Infections Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 21
Helicobacter pylori Infections Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22
Helicobacter pylori Infections Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23
Helicobacter pylori Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24
Helicobacter pylori Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 25
Helicobacter pylori Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26
Helicobacter pylori Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27
Helicobacter pylori Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 29
GlobalData Methodology 284